TransCode Therapeutics

-$0.09 (-3.15%) Today
+$0.01 (+0.36%) As of 11:27 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.

About RNAZ

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

CEO
Robert Michael Dudley
Employees
6
Headquarters
Boston, Massachusetts
Founded
2016

RNAZ Key Statistics

Market Cap
35.75M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
205.87K
High Today
$2.87
Low Today
$2.73
Open Price
$2.87
Volume
146.92K
52 Week High
$7.00
52 Week Low
$2.35

RNAZ Earnings

$0.00
$0.17
$0.34
$0.51
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure